Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

535.27

+19.93 (3.87%)

At close: Aug 11, 2026, 4:00 PM EDT

539.00

+3.73 (0.70%)

Pre-market: Aug 12, 2026, 9:15 AM EDT

Madrigal Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	292.73	198.69	100.02	99.92	331.55	36.27
Short-Term Investments	546.03	784.87	826.23	534.22	27.23	234.08
Cash & Short-Term Investments	838.75	983.56	926.25	634.13	358.77	270.35
Cash Growth	5.24%	6.19%	46.07%	76.75%	32.71%	-4.86%
Accounts Receivable	192.31	134.48	53.82	-	-	-
Inventory	99.39	74.84	34.07	-	-	-
Other Current Assets	68.73	52.89	18.79	3.15	2.6	1.34
Total Current Assets	1,199	1,246	1,033	637.28	361.37	271.68
Net Property, Plant & Equipment	17.17	6.44	4.59	3.27	1.2	1.65
Other Intangible Assets	7.19	7.38	4.73	-	-	-
Other Long-Term Assets	21.11	-	-	-	-	-
Total Assets	1,245	1,260	1,042	640.55	362.57	273.33
Accounts Payable	34.51	48.88	43.6	28.04	23.83	21.38
Accrued Expenses	338.66	260.39	124.7	89.98	91.46	55.05
Current Portion of Leases	1.03	1.02	0.98	0.53	0.6	0.41
Total Current Liabilities	374.2	310.29	169.28	118.55	115.89	76.84
Long-Term Debt	340.79	339.88	117.57	115.48	49.29	-
Long-Term Leases	5.92	6.73	1.02	1.19	-	0.39
Total Long-Term Liabilities	346.72	346.61	118.59	116.67	49.29	0.39
Total Liabilities	720.92	656.9	287.86	235.21	165.18	77.23
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	2,766	2,692	2,556	1,741	1,160	863.5
Accumulated Other Comprehensive Income	0.81	0.87	0.47	0.47	-0.03	-0.08
Retained Earnings	-2,243	-2,090	-1,802	-1,336	-962.66	-667.31
Shareholders' Equity	523.72	602.69	754.38	405.33	197.39	196.11
Total Liabilities & Equity	1,245	1,260	1,042	640.55	362.57	273.33
Total Debt	347.75	347.63	119.57	117.19	49.89	0.8
Net Cash (Debt)	491	635.93	806.68	516.94	308.88	269.55
Net Cash Growth	-27.05%	-21.17%	56.05%	67.36%	14.59%	-4.88%
Net Cash Per Share	17.93	28.35	37.92	27.66	18.02	16.30
Book Value	523.72	602.69	754.38	405.33	197.39	196.11
Book Value Per Share	19.13	26.86	35.46	21.69	11.52	11.86
Tangible Book Value	516.54	595.31	749.65	405.33	197.39	196.11
Tangible Book Value Per Share	18.87	26.54	35.24	21.69	11.52	11.86

SEC Filings: 10-K · 10-Q